Business News

Sorrento: Near-Term Developments Could Catapult Shares Higher


Anyone keeping track of the progress being made at Sorrento Therapeutics (SRNE), will be aware the company has a bulging pipeline encompassing a wide spectrum of drugs, ranging from cancer to pain to lymphatic delivery systems.

One part of the portfolio…



Click here to view the original article.

Related Posts

You might also like ...